H.Res. 342 · 119th Congress (2025–2027)
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.Res. 342’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. James P. McGovern (D-MA-2)
- Policy area
- Health
- Subjects
- Cancer
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Medical research
- Prescription drugs
- Research administration and funding
- Sex and reproductive health
- Women's health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Submitted in House
Document: Introduced in House
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (1)
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Official title, Display title · Introduced in House